Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Enhanced recovery after surgery (ERAS) has been reported to be associated with improved outcomes in many studies, most of which involve short-term effects. Only a few studies have reported the long-term effects of highly compliant ERAS. However, to the best of our knowledge, there are no large-scale comparisons between incomplete ERAS (compliance < 70%) and non-ERAS. The aim of this comparative study is to analyze and evaluate the long-term outcomes of incomplete ERAS in laparoscopic colorectal cancer surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Incomplete ERAS | Incomplete ERAS was defined as ERAS compliance < 70%. |
| |
| Non-ERAS | non-ERAS was defined as not executing any ERAS programs. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ERAS protocol | Procedure | ERAS protocol is a series of procedures that enhance the recovery of surgical patients. Patients were grouped according to whether the procedure was attempted. |
| Measure | Description | Time Frame |
|---|---|---|
| long-term survival | 5-year Disease free survival and overall survival | Each patient will be followed for 5 years or until death |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative complications | Postoperative complications within 30 days after surgery. | within 30 days after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
In this study, we are going to collect clinical data of patients undergoing laparoscopic radical surgery from four large hospitals between August 2008 and December 2016.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chenxing Jian, MD. | Contact | 86-13959538950 | ptyyjcx@126.com |
| Name | Affiliation | Role |
|---|---|---|
| Xiaogang Shu, MD.,PHD. | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. | Recruiting | Wuhan | Hubei | 430000 | China |
After the funders finished the study,the data will be available,if approved by PI.
After 2025.1.1
Approved by PI
Not provided
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
| Union Hospital,Tongji Medical College, Huazhong University of Science and Technology. | Active, not recruiting | Wuhan | Hubei | 430000 | China |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |